Evidence map›Paper›PMID 38403677›Full record

ArticleScientific reports2024

Process optimization for gold nanoparticles biosynthesis by Streptomyces albogriseolus using artificial neural network, characterization and antitumor activities.

Noura El-Ahmady El-Naggar, Asmaa A El-Sawah, Mohamed F Elmansy, Omar T Elmessiry, Mohanad E El-Saidy, Mostafa K El-Sherbeny, Mohamed T Sarhan, Aya Amin Elhefnawy, Shimaa R Dalal

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Antimicrobial Activity ofInternational journal of molecular sciences · 2024
    Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Noura El-Ahmady El-NaggarDepartment of Bioprocess Development, Genetic Engineering and Biotechnology Research Institute, City of Scientific Research and Technological Applications (SRTA-City), New Borg El- Arab City, Alexandria, 21934, Egypt. nouraalahmady@yahoo.com.ORCID 0000-0001-8493-9194
Asmaa A El-SawahBotany Department, Faculty of Science, Mansoura University, Mansoura, 35516, Egypt.
Mohamed F ElmansyBiotechnology and its Application Program, Department of Botany, Faculty of Science, Mansoura University, Mansoura, 35516, Egypt.
Omar T ElmessiryBiotechnology and its Application Program, Department of Botany, Faculty of Science, Mansoura University, Mansoura, 35516, Egypt.
Mohanad E El-SaidyBiotechnology and its Application Program, Department of Botany, Faculty of Science, Mansoura University, Mansoura, 35516, Egypt.
Mostafa K El-SherbenyBiotechnology and its Application Program, Department of Botany, Faculty of Science, Mansoura University, Mansoura, 35516, Egypt.
Mohamed T SarhanBiotechnology and its Application Program, Department of Botany, Faculty of Science, Mansoura University, Mansoura, 35516, Egypt.
Aya Amin ElhefnawyBiotechnology and its Application Program, Department of Botany, Faculty of Science, Mansoura University, Mansoura, 35516, Egypt.
Shimaa R DalalBotany Department, Faculty of Science, Mansoura University, Mansoura, 35516, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gold nanoparticles (GNPs) are highly promising in cancer therapy, wound healing, drug delivery, biosensing, and biomedical imaging. Furthermore, GNPs have anti-inflammatory, anti-angiogenic, antioxidants, anti-proliferative and anti-diabetic effects. The present study presents an eco-friendly approach for GNPs biosynthesis using the cell-free supernatant of Streptomyces albogriseolus as a reducing and stabilizing agent. The biosynthesized GNPs have a maximum absorption peak at 540 nm. The TEM images showed that GNPs ranged in size from 5.42 to 13.34 nm and had a spherical shape. GNPs have a negatively charged surface with a Zeta potential of - 24.8 mV. FTIR analysis identified several functional groups including C-H, -OH, C-N, amines and amide groups. The crystalline structure of GNPs was verified by X-ray diffraction and the well-defined and distinct diffraction rings observed by the selected area electron diffraction analysis. To optimize the biosynthesis of GNPs using the cell-free supernatant of S. albogriseolus, 30 experimental runs were conducted using central composite design (CCD). The artificial neural network (ANN) was employed to analyze, validate, and predict GNPs biosynthesis compared to CCD. The maximum experimental yield of GNPs (778.74 μg/mL) was obtained with a cell-free supernatant concentration of 70%, a HAuCl

Indexed as

Metal NanoparticlesStreptomycesDoxorubicinGoldHumansDoxorubicinGoldArtificial neural networkBiosynthesisCentral composite designCharacterizationGNPsHeP-G2 human cancer cell lineProcess optimizationStreptomyces albogriseolus

Identifiers

PMID38403677
PMCPMC10894868

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.